CERE Deadline: CERE Investors with Losses in Excess of $100K Have Opportunity to Lead Cerevel Therapeutics Holdings, Inc. Securities Fraud Lawsuit

NEW YORK, May 25, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds all persons or entities that: (1) sold or otherwise disposed of the publicly-traded common stock of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) during the period from October 11, 2023...